[EN] PYRIMIDO[4,5-B]INDOLE DERIVATIVES AND USE THEREOF IN THE EXPANSION OF HEMATOPOIETIC STEM CELLS [FR] DÉRIVÉS DE PYRIMIDO[4,5-B]INDOLE ET LEUR UTILISATION DANS L'EXPANSION DES CELLULES SOUCHES HÉMATOPOÏÉTIQUES
PYRIMIDO[4,5-B]INDOLE DERIVATIVES AND USE THEREOF IN THE EXPANSION OF HEMATOPOIETIC STEM CELLS
申请人:UNIVERSITÉ DE MONTRÉAL
公开号:US20150011543A1
公开(公告)日:2015-01-08
Pyrimido[4,5-b]indole derivatives are provided. These compounds are useful to expand hematopoietic stem cell populations, particularly, human hematopoietic stem cell populations. The compounds are also useful in the medical treatment of diseases that involve hematopoietic stem cells.
Pyrimido[4,5-B]indole derivatives and use thereof in the expansion of hematopoietic stem cells
申请人:UNIVERSITÉ DE MONTRÉAL
公开号:US10336747B2
公开(公告)日:2019-07-02
Pyrimido[4,5-b]indole derivatives are provided. These compounds are useful to expand hematopoietic stem cell populations, particularly, human hematopoietic stem cell populations. The compounds are also useful in the medical treatment of diseases that involve hematopoietic stem cells.
Methods and compositions relating to hematopoietic stem cell expansion, enrichment, and maintenance
申请人:CHILDREN'S MEDICAL CENTER CORPORATION
公开号:US10669528B2
公开(公告)日:2020-06-02
The methods and compositions described herein relate to producing, expanding, enriching, and/or maintaining hematopoietic stem cells ex vivo by treating the cells with an agent(s) that exhibits two or more activities selected from modulation of histone methylation; inhibition of TGFβ signaling; inhibition of p38 signaling; activation of canonical Wnt signaling; and modulation of histone acetylation. In some embodiments, the technology described herein relates to transplantation of hematopoietic stem cells.
METHODS AND COMPOSITIONS RELATING TO HEMATOPOIETIC STEM CELL EXPANSION
申请人:Children's Medical Center Corporation
公开号:EP3429603B1
公开(公告)日:2021-12-29
METHODS AND COMPOSITIONS RELATING TO HEMATOPOIETIC STEM CELL EXPANSION, ENRICHMENT, AND MAINTENANCE
申请人:CHILDREN'S MEDICAL CENTER CORPORATION
公开号:US20180187156A1
公开(公告)日:2018-07-05
The methods and compositions described herein relate to producing, expanding, enriching, and/or maintaining hematopoietic stem cells ex vivo by treating the cells with an agent(s) that exhibits two or more activities selected from modulation of histone methylation; inhibition of TGFβ signaling; inhibition of p38 signaling; activation of canonical Wnt signaling; and modulation of histone acetylation. In some embodiments, the technology described herein relates to transplantation of hematopoietic stem cells.